SBT-77-7101

N/A

Report date: 2024/11/26 09:49:53

Base Information

Drug NameSBT-77-7101

Drug Alias NameSBT777101

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of Actioncitrullinated proteins modulatorsT-cell receptor modulators

TargetsT-cell receptor

Therapy Area/IndicationsArthritis, RheumatoidHidradenitis Suppurativa

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSonoma Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesSonoma Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsArthritis, RheumatoidHidradenitis Suppurativa

Inactive IndicationsN/A

Other Information

ATC CodeN/A